VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Vokes on HPV-Related Head and Neck Cancer

Everett E. Vokes, MD
Published: Thursday, Aug 29, 2013


Everett E. Vokes, MD, Giant of Cancer Care in the Head and Neck Cancer Category, John E. Ultmann Professor of Medicine and Radiation Oncology, Physician-in-Chief, University of Chicago Medicine and Biological Sciences, discusses HPV-related head and neck cancer

As smoking rates in the U.S. have decreased, Vokes says, so has the number of cases of head and neck cancers associated with classic risk factors. However, there has been an emergence of HPV-driven tumors that are affecting the base of the tongue and the tonsils.

HPV is a sexually transmitted disease that affects males to females in a 3:1 ratio, Vokes says. The virus attacks the oropharynx and the base of the tongue.

Vokes says the patients with HPV receive similar treatment to patients with head and neck cancer induced by classic risk factors but the prognosis and cure rate of the patients with HPV are much higher. The oncology community has begun to question the need to be as aggressive in the treatment of HPV-related head and neck cancer.


Everett E. Vokes, MD, Giant of Cancer Care in the Head and Neck Cancer Category, John E. Ultmann Professor of Medicine and Radiation Oncology, Physician-in-Chief, University of Chicago Medicine and Biological Sciences, discusses HPV-related head and neck cancer

As smoking rates in the U.S. have decreased, Vokes says, so has the number of cases of head and neck cancers associated with classic risk factors. However, there has been an emergence of HPV-driven tumors that are affecting the base of the tongue and the tonsils.

HPV is a sexually transmitted disease that affects males to females in a 3:1 ratio, Vokes says. The virus attacks the oropharynx and the base of the tongue.

Vokes says the patients with HPV receive similar treatment to patients with head and neck cancer induced by classic risk factors but the prognosis and cure rate of the patients with HPV are much higher. The oncology community has begun to question the need to be as aggressive in the treatment of HPV-related head and neck cancer.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x